Cincinnati Transplant Tumor Registry
Recurrence rate of 50% and a 5-year survival of 28%.
The Mayo Clinic Protocol
External beam radiation to 45 Gy with continuous infusional 5-
fluorouracil followed by intrabiliary radiation and oral capecitabine
until the time of OLT. 5-year survival of 73%.
Predictors of recurrence following OLT were elevated CA 19-9
>500 U/ml (Hazard ratio [HR] of 1.8), portal vein encasement (HR:
3.3) and residual tumor on explant (HR: 9.8).